NOTE AND WARRANT PURCHASE AGREEMENTNote and Warrant Purchase Agreement • April 13th, 2010 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • Illinois
Contract Type FiledApril 13th, 2010 Company Industry JurisdictionTHIS NOTE AND WARRANT PURCHASE AGREEMENT, dated as of April 7, 2010 (this “Agreement”), is entered into by and between RADIENT PHARMACEUTICALS CORPORATION, a Delaware corporation with headquarters located at 2492 Walnut Ave., Suite 100
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 13th, 2010 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations • Illinois
Contract Type FiledApril 13th, 2010 Company Industry JurisdictionThis Registration Rights Agreement (this “Agreement”) dated as of April 7, 2010, is made by and between Radient Pharmaceuticals Corporation, a Delaware corporation located at 2492 Walnut Ave., Tustin, California 92780 (the “Company”), and _______________________________________________ (the “Investor”).
ContractRADIENT PHARMACEUTICALS Corp • April 13th, 2010 • Pharmaceutical preparations • Illinois
Company FiledApril 13th, 2010 Industry JurisdictionTHIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SUCH ACT AND ANY APPLICABLE STATE SECURITIES LAW OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO RADIENT PHARMACEUTICALS CORPORATION THAT SUCH REGISTRATION IS NOT REQUIRED.
RADIENT PHARMACEUTICALS CORPORATION FINAL ADDENDUM TO NOTE AND WARRANT PURCHASE AGREEMENT DATED: APRIL 8, 2010Note and Warrant Purchase Agreement • April 13th, 2010 • RADIENT PHARMACEUTICALS Corp • Pharmaceutical preparations
Contract Type FiledApril 13th, 2010 Company IndustryThis Addendum to Note and Warrant Purchase Agreement is executed this 12th day of April, 2010 with reference to the following facts: